MCAK belongs to the Kinesin-13 family, whose members depolymerize microtubules rather than translocate along them. We defined the minimal functional unit of MCAK as the catalytic domain plus the class specific neck (MD-MCAK), which is consistent with previous reports. We used steady-state ATPase kinetics, microtubule depolymerization assays, and microtubule•MCAK cosedimentation assays to compare the activity of full-length MCAK, which is a dimer, with MD-MCAK, which is a monomer.
Introduction
Microtubules (MTs) are cytoskeletal polymers that serve two main cellular functions: they form tracks on which molecular motor proteins sort and deliver cellular components (Hirokawa and Takemura, 2004 ) and they are essential for the assembly of the mitotic spindle .
MTs are made of α/β tubulin heterodimers that assemble longitudinally to form protofilaments, 13 of which associate laterally to form the MT. MTs exhibit a behavior known as dynamic instability, in which populations of MTs coexist in states of growth and shrinkage and interconvert randomly between these two states (Desai and Mitchison, 1997; Nogales, 2000) . Although solutions of purified tubulin exhibit dynamic instability, cellular factors have been shown to be important modulators of MT dynamics (Cassimeris and Spittle, 2001) .
One important class of MT regulatory proteins is the Kinesin-13 family (Lawrence et al., 2004; Miki et al., 2005) . Kinesin-13 family members, including MCAK (Kif2C), pKinI, and Kif2A, depolymerize MTs in vitro (Desai et al., 1999; Moores et al., 2002; Hunter et al., 2003) and regulate MT dynamics and chromosome segregation in cells (Maney et al., 1998; Maney et al., 2001; Kline-Smith and Walczak, 2002; Rogers et al., 2004) . In addition to its important function in mitosis (Gaetz and Kapoor, 2004; Ganem and Compton, 2004) , Kif2A is also required for proper neuronal outgrowth (Morfini et al., 1997; Homma et al., 2003) .
MCAK is a homodimeric molecule that can depolymerize stabilized MTs as well as dynamic
MTs in vitro (Desai et al., 1999; Hunter et al., 2003; Newton et al., 2004) . It is composed of an Nterminal globular domain that functions in subcellular targeting (Maney et al., 1998; Wordeman et al., 1999; Walczak et al., 2002; , a class-specific neck and catalytic core that are essential for MT depolymerization activity (Maney et al., 2001; Ovechkina et al., 2002; Ogawa et al., 2004) , and a C-terminal tail that plays a role in dimerization and regulates ATPase activity (Maney et al., 2001; Moore and Wordeman, 2004) . While the native protein is dimeric, a monomeric form consisting of the neck and catalytic core is sufficient for MT depolymerization in vitro and in cells (Maney et al., 2001) . It was originally proposed that a dimeric molecule would be necessary to push apart the lateral interactions of the protofilaments of the MT lattice, but this hypothesis appears not to be true as MCAK was shown to act on a single protofilament during depolymerization (Niederstrasser et al., 2002) . The mechanistic significance for a two-headed molecule in vivo is therefore unknown.
The MT binding properties of Kinesin-13s are distinct from other kinesin superfamily members.
Both MCAK and Kif2A bind to tubulin heterodimers and to the MT lattice, but appear to exhibit a preference for the ends of MTs (Desai et al., 1999; Moore and Wordeman, 2004) . Physiologically, this end binding activity may be important for the recently discovered tip-tracking activity of Kinesin-13s (Mennella et al., 2005; Moore et al., 2005) . Mechanistically, this end binding is likely critical as the ATPase activity is preferentially stimulated by MT ends (Hunter et al., 2003; Moores et al., 2003) .
However, the ATPase activity is also stimulated in the presence of tubulin heterodimers (Moores et al., 2002; Hunter et al., 2003; Moores et al., 2003; Moore and Wordeman, 2004; Shipley et al., 2004) .
Significant insight into how Kinesin-13 family members function including a potential role for the class-specific neck has been provided in the recently reported crystal structure of monomeric forms of Kif2C and pKinI (Ogawa et al., 2004; Shipley et al., 2004) . Although the fold and placement of nucleotide in Kinesin-13s are conserved with those of other kinesins (Sack et al., 1999) , the state of the ATP binding pocket is distinct, suggesting that Kinesin-13s may utilize their ATPase cycle differently than conventional kinesin. Interestingly, in silico modeling demonstrates that the Kinesin-13 structures fit better to curved protofilaments (Ogawa et al., 2004; Shipley et al., 2004) , which are believed to be intermediates of MT depolymerization. In addition, the neck of Kif2C may associate laterally between the protofilaments of the MT, indicating that the neck may be crucial for MT destabilization (Ogawa et al., 2004) .
In this study we compare the activity of two Xenopus MCAK proteins to further probe the mechanistic cycle of MT depolymerization. We explored the catalytic differences between dimeric, full length MCAK (FL-MCAK) and monomeric, minimal domain MCAK (MD-MCAK). Although the minimal domain of mammalian MCAK has been previously identified in cellular assays, it has never been fully characterized biochemically in comparison to full length MCAK. Our data show that monomeric MD-MCAK exhibits significantly different properties when compared to FL-MCAK. We propose that dimerization plays an important role in the catalytic cycle of MCAK-promoted MT depolymerization by enhancing the ability of MCAK to target to MT ends and by increasing the dissociation of the MCAKtubulin heterodimer complex. The overall effect is to increase the free MCAK available for MT end binding to drive another cycle of ATP-promoted MT depolymerization.
Materials and Methods

Cloning and transfection of deletion constructs
MCAK deletion constructs were created by PCR amplification of Xenopus MCAK library clone pBS11B using sequence specific primers and cloned back into pEGFPC1 using SacI and EcoRV restriction sites or KpnI and Hind III sites. Constructs for protein purification were cloned into pFastBac1 or pFastBac1-GFP using SacI and KpnI restriction sites. pFastBac1-GFP was created by PCR amplification of the EGFP sequence from pEGFPC1 and cloned into the BamHI and SacI sites of pFastBac1. All constructs were verified by DNA sequence analysis. Constructs were transfected into PtK2 cells, and fixed and stained as previously described . Cells were then categorized based on the intensity of GFP fluorescence. Cells expressing a moderate level of GFP fluorescence were scored without knowledge of the MCAK transfection construct, and the percentage of cells with destabilized MT arrays was determined for 40-100 cells per transfection as described previously . Images were acquired using a Nikon E-600 with a 40X 1.0 Plan Apo objective and a MicroMax 1300 Y camera (Princeton Instruments). The camera, shutters, and filters were controlled by Metamorph (Universal Imaging).
Protein expression and purification
FL-MCAK (MCAK amino acids 2-731) and MD-MCAK (MCAK amino acids 187-592) protein were expressed in either Sf9 or HighFive insect cells using the Bac-to-Bac baculovirus expression system (Invitrogen). Purification of FL-MCAK, GFL-MCAK (GFP-tagged FL-MCAK), and GMD-MCAK (GFP-tagged MD-MCAK) was as previously described (Desai et al., 1999) . MD-MCAK was purified similarly to FL-MCAK, except MD-MCAK purified to near homogeneity with the first cation exchange column and did not require further purification. All protein concentrations are reported in terms of monomer and were determined using gel densitometry of Coomassie stained gels relative to a BSA standard and quantified by NIH image. Because the predicted molecular weight of MD-MCAK is roughly half that of the predicted molecular weight of FL-MCAK, the band intensities of equal molar concentrations of MD-MCAK and FL-MCAK on Coomassie stained gels (Figures 2 and 6 ) are not equal.
Multiple preparations of both FL-MCAK and MD-MCAK were used in all experiments.
Molecular Weight Determination
Molecular weights were determined using multiple preps of all proteins at equal concentrations. Stokes radii were determined using a Superose 6 10/300 GL column in 400 mM KCl, 20 mM PIPES, 1 mM MgCl 2 , 1 mM EGTA, 0.1 mM EDTA, 1 mM DTT, 10 µM MgATP, 0.1 µg/mL LPC using blue dextran, thyroglobulin, β-amylase, alcohol dehydrogenase, BSA (bovine serum albumin), carbonic anhydrase, and cytochrome C as standards. Protein peaks were detected by A 280 readings, by Coomassie Brilliant Blue stained gels, or by Western blot. Stokes radii were calculated as an average of Laurent and Killander and Porath plots (Porath and Flodin, 1959; Laurent and Killander, 1964) . S values were determined using BSA, catalase, ovalbumin, carbonic anhydrase, and alcohol dehydrogenase as standards. Sucrose gradients were run in 100 mM KCl (or 400 mM KCl), 20 mM PIPES, 1 mM MgCl 2 , 1 mM EGTA, 0.1 mM EDTA, 1 mM DTT, 10 µM MgATP, 0.1 µg/mL LPC (chymostatin, pepstatin A, leupeptin) through a 5-20% sucrose gradient in a Beckman SW55 rotor for 15 hours at 4°C. 250 µl fractions were collected manually, and protein peaks were detected by Western, Bradford reagent or by GFP fluorescence with similar results. Molecular weights were calculated with Equation 1:
Eq. 1 M = (6π * R s * A * S*η)/(1-υρ) M is the molecular weight, R s is the Stokes radius, A is Avagadro's number, S is the sedimentation value, η is the solvent viscosity, υ is the calculated protein density from the amino acid composition, ρ is the solvent density (Siegel and Monty, 1966) .
Preparation of MT substrates
GMPCPP-stabilized MTs were polymerized from cycled bovine tubulin as previously described (Desai and Walczak, 2001) . Briefly, tubulin was clarified with a high-speed spin for 5 minutes at 2 o C in a TLA100 rotor (Beckman) and then polymerized in the presence of 0.5 mM GMPCPP (Jena Scientific), 1X BRB80 (80 mM PIPES pH 6.8, 1 mM MgCl 2 , 1 mM EGTA), 1 mM DTT for 30 minutes at 37°C. The MTs were then pelleted for 5 minutes in a TLA100 rotor at 37°C and resuspended in 1X BRB80, 1 mM DTT. GMPCPP-and paclitaxel-stabilized MTs were made in a similar manner except that paclitaxel was added to 10 µM at 20 minutes after the start of polymerization. After pelleting, MTs were resuspended in 1X BRB80, 1 mM DTT, 10 µM paclitaxel. To determine the average length of the MTs, MTs were polymerized in an identical manner using rhodamine-labeled tubulin, squashed onto coverslips and visualized by fluorescence microscopy.
MT depolymerization assays
Depolymerization assays were performed using GMPCPP-stabilized MTs. For a direct comparison between fixed amounts of FL-MCAK and MD-MCAK, 50 nM enzyme was incubated at room temperature in 1.5X BRB80, 42 mM KCl, 2 mM MgATP, and 1.5 µM MTs. In assays to determine the EC 50 , FL-or MD-MCAK was titrated in a reaction (0-128 nM) that included 1 µM MTs. All reactions were incubated for 15 minutes at 22°C, and subsequently centrifuged in a Beckman TLA 100 rotor for 5 minutes at 90,000 rpm at 22°C. The pellet was resuspended in the original volume of 1X BRB80, and the supernatants and pellets were mixed with equal volumes of 2X Laemmli sample buffer (SB), boiled, and equal volumes were electrophoresed on a 10% SDS-PAGE gel. The gels were stained with Coomassie Brilliant Blue, scanned, and the fraction of soluble tubulin heterodimer was quantified by densitometry of the stained gel using NIH image. In all cases the amount of tubulin depolymerized in the absence of enzyme was subtracted as background so that the percent of microtubules depolymerized is that from enzyme addition only. The data from at least three independent experiments were combined and fit to the four-parameter logistic equation or dose-response curve (Eq. 2), and the EC 50 was calculated for FL-and MD-MCAK using GraFit 5 software where Response is the fraction of tubulin heterodimer in the supernatant, A min is the baseline or background response, A max is the maximal response, logEC 50 is the log of the effective concentration that gives a 50% response, X is the log of the enzyme concentration, and H is the Hill slope.
MCAK MT cosedimentation assays
The cosedimentation assays shown in Figure 2 were performed using GMPCPP-and paclitaxel-stabilized MTs (doubly stabilized) as previously described (Foster et al., 1998) . Equal molar concentrations (1.24 µM) of purified protein (MD-MCAK or FL-MCAK) were incubated in 1.25X BRB80, 100 mM KCl, and increasing concentrations of doubly stabilized MTs (0.25 µM-8 µM). The reactions were pelleted at 90,000 rpm in a Beckman TLA 100 rotor. The pellet of each reaction was resuspended in 1X BRB80
equal to the volume of its supernatant, and then the supernatant and pellet were diluted with equal amounts of 2X SB. Equal volumes of each sample were analyzed by SDS-PAGE and stained with Coomassie Blue. The concentration of MCAK partitioning to the supernatant and pellet was quantified by densitometry of the stained gel using NIH image. The data from at least three independent experiments were fit to Equation 3 to determine the apparent K d of FL-or MD-MCAK for MTs where MT•E is the concentration of MCAK partitioning to the pellet with the MTs. MT t is the tubulin concentration as MTs, and E 0 is the total MCAK concentration.
Fluorescence based MT binding assays
End binding assays were performed similarly to Desai et al. (1999) . Briefly, 9 nM GFL-MCAK or GMD-MCAK was incubated with 400 nM GMPCPP-stabilized MTs in 1.5X BRB80, 100 mM KCl, plus or minus 5 mM nucleotide (MgAMPPNP or MgADP) for 15 minutes at 22°C (Figure 3 ). Reactions were fixed in 1% gluteraldehyde, diluted, and subsequently loaded onto 10% glycerol cushions in 1XBRB80.
Reactions were sedimented for 45 minutes at 12,000 rpm at 20°C in a Beckman JS13.1 rotor onto poly-Llysine coated coverslips, which were processed for immunofluorescence to enhance the GFP signal. Anti-GFP antibodies were raised in rabbits to recombinant EGFP and affinity-purified before use. All subsequent steps were carried out at room temperature. The coverslips were blocked in AbDil [2% BSA, 0.1% NaN 3 in TBS-TX (20 mM Tris, 150 mM NaCl, pH 7.5 + 0.1% Triton X-100)] for 30 min. All subsequent rinses between antibody incubations were performed using TBS-TX. Coverslips were incubated in primary anti-GFP antibody diluted to 2 µg/ml in Ab Dil for 30 min. They were washed in TBS-TX and incubated in 1/50 goat anti-rabbit FITC (Jackson). To visualize MTs, the coverslips were stained with 1/250 DM1α (Sigma) followed by 1/50 donkey anti-mouse Texas Red (Jackson). Images were acquired from at least three independent experiments using a Micromax 1300 Y camera attached to a Nikon E-600 microscope with a 100X 1.3 Plan Fluor objective. To control for any non-specific background binding of our anti-GFP antibody, we also performed the assay in the absence of enzyme. In no enzyme controls, >98% of the MTs had no staining. Within each independent experiment, photomicrographs were scaled similarly based on the average GFP fluorescence. MTs with binding events were then scored without knowledge of the sample identity. All binding events were compiled in Microsoft Excel and then analyzed using the student t-test.
Steady-State ATPase assays
ATPase assays were performed using the Malachite green colorimetric assay to detect inorganic phosphate (P i ) (Lanzetta et al., 1979) . For these experiments, 50 nM FL-or MD-MCAK was incubated with 2 mM MgATP, 50 mM KCl, 1 mg/mL casein, 1.25X BRB80, and varying concentrations (0-20µM) of tubulin heterodimer or doubly-stabilized MTs for 30-60 minutes at 25°C. The rate of P i release was linear over this time course. Data were collected and analyzed from at least three independent experiments, and the plots represent the average of these experiments. The microtubule concentration dependence data in Figure 5A were fit to the quadratic equation (Eq. 4) because some of the microtubule concentrations used in the experiment were similar to the concentration of MCAK. The data in Figure   5B -C were fit to the Michaelis-Menten equation (Eq. 5). For Figure 5C , the MgATP concentration was varied (0-1 mM) with doubly-stabilized MTs held constant at 8 µM for FL-MCAK and 4 µM for MD-MCAK. The ATPase rates are reported per active site. Note that the MT concentration for FL-MCAK at 8 µM was sub-saturating; therefore, the k cat obtained from the ATP concentration dependence experiment ( Figure 5C ) was somewhat lower than the k cat obtained from the MT concentration dependence ( Figure   5A ).
S is the substrate concentration (tubulin heterodimer or MgATP), k cat is the maximum rate constant of steady-state ATP turnover, E 0 is the MCAK concentration, MT t is the microtubule concentration, K 0.5,MT is the steady-state Michaelis constant for MTs and represents the concentration needed to provide one-half the maximal velocity. K corresponds to the Michaelis constant for tubulin (K 0.5,Tubulin ) or ATP (K m,ATP ) and is the concentration of tubulin heterodimer or ATP, respectively, necessary to provide one-half the maximal velocity.
Competition binding assays
To test the hypothesis that soluble tubulin heterodimer sequestered MD-MCAK, we designed a MT•MCAK cosedimentation assay using soluble tubulin heterodimer to compete with the binding sites on the MT polymer ( Figure 6 ). In this experiment 500 nM FL-or MD-MCAK was incubated with 3.25 µM doubly stabilized MTs, 1.25X BRB80, and 100 mM KCl in the presence of increasing concentrations of soluble tubulin heterodimer (0-13 µM) plus 250 µM GDP for 15 minutes. The GDP was added to decrease the ability of the added tubulin heterodimer to assemble into MT polymer. After centrifugation, the supernatant and pellet of each reaction were adjusted to equal volumes and electrophoresed on 10% SDS-PAGE gels. Colloidal Coomassie stained gels from three independent experiments were quantified using Image J software.
The fraction of MCAK partitioning to the pellet was normalized to the amount of MCAK sedimenting with the MT pellet in the absence of additional soluble tubulin heterodimer (i.e., 0:1 reactions). The results are presented as a ratio of soluble tubulin heterodimer to MT polymer. A ratio of 1:1 represents 3.25 µM soluble tubulin heterodimer + 3.25 μM MTs; a ratio of 2:1 represents 6.5 μM soluble tubulin heterodimer + 3.25 μM MTs; and a ratio of 4:1 represents 13 μM soluble tubulin heterodimer + 3.25 μM MTs.
Results
The identification of the minimal domain of MCAK necessary for MT depolymerization
To initiate our biochemical investigations of what features of Xenopus MCAK are required for MT depolymerization activity, we first needed to determine the minimal domain of MCAK necessary to depolymerize MTs. We screened a series of GFP-fusion constructs in which MCAK sequences were deleted using a cellular-based transfection assay (Kline-Smith and and found that the minimal domain of MCAK necessary for efficient depolymerization activity is contained within residues 187-592; we refer to these residues as the minimal domain of MCAK (MD-MCAK) ( Figure S1 , Table   S1 ). The MD-MCAK characterized here is similar in sequence to other MCAK monomers used for cellular and structural studies (Maney et al., 2001; Ogawa et al., 2004) .
MD-MCAK is monomeric and depolymerizes MTs in vitro
To analyze the catalytic mechanism of MCAK, we expressed and purified FL-MCAK and MD-MCAK, as well as GFP fusions of both proteins for biochemical assays (GFL-MCAK and GMD-MCAK) ( Figure 1A , B). We tested each pure protein in a sedimentation-based MT depolymerization assay and found that substoichiometric amounts of MD-MCAK depolymerized GMPCPP-stabilized MTs as well as FL-MCAK ( Figure 1C) , showing that both FL-MCAK and MD-MCAK (as well as the GFP fusion proteins) catalytically depolymerize MTs.
Because the C-terminus of MCAK contains a weak coiled-coil domain and interacts with itself in yeast two-hybrid assays (our unpublished data), we performed hydrodynamic analysis of all proteins to determine their estimated molecular mass. We found that FL-MCAK and GFL-MCAK are dimeric, but that MD-MCAK and GMD-MCAK are monomeric ( Figure 1D ). Because MD-MCAK is the smallest functional unit of MCAK that exhibited activity equal to that of FL-MCAK in our cellular assay, and because it is monomeric, we used it to probe the mechanistic differences between MT depolymerization induced by MD-MCAK in direct comparison to FL-MCAK.
FL-MCAK binds with greater specificity to MT ends than MD-MCAK
We first measured the binding affinity of FL-or MD-MCAK for MTs using a cosedimentation assay in the absence of added nucleotides (Figure 2 ). In this experiment the MTs were doubly stabilized with paclitaxel and GMPCPP to minimize destabilization of the MTs during the reaction. We found that both FL-MCAK and MD-MCAK exhibited similar microtubule affinities (0.84 μΜ for FL-MCAK versus 0.70 μΜ for MD-MCAK). In these cosedimentation assays, the concentration of MCAK (1.24 μΜ) to MT (0-8 μΜ tubulin) was much higher than in our depolymerization assays ( Figures 1 and 4) ; therefore the high affinity end binding sites for MCAK on the MT are saturated, and MCAK is binding to the MT lattice as well. Thus, the experimentally determined K d in this experiment is a composite constant reflecting the affinity for both the MT ends and the MT lattice. These results indicate that MCAK is capable of binding to the MT lattice, but the K d observed is weaker than the 37-620 nM constants that have been reported for conventional kinesin (Kinesin-1), Ncd (Kinesin-14), and monomeric Eg5
(Kinesin-5), all of which translocate along MTs (Crevel et al., 1996; Foster et al., 1998; Cochran et al., 2005) . Our next experiments were designed to evaluate the MT end binding behavior of MCAK.
Previous work indicates that MCAK binds specifically to MT ends when MCAK is substoichiometric to the tubulin concentration (Desai et al., 1999; Hunter et al., 2003; Moore and Wordeman, 2004) . We therefore wanted to determine if MD-MCAK had similar end binding properties to FL-MCAK. To discriminate between the end binding and lattice-binding properties of MCAK, we incubated substoichiometric concentrations of GFL-MCAK or GMD-MCAK with MTs in the presence of varying nucleotide conditions, and then visualized the MTs by immunofluorescence microscopy ( Figure   3 ) (Desai et al., 1999; Hunter et al., 2003; Moore and Wordeman, 2004) .
In the absence of added nucleotide and at a molar ratio of one MCAK head to 44 tubulin heterodimers, GFL-MCAK was bound to 76 ± 5% of the MTs ( Figure 3A , J) and was highly enriched at the ends of MTs ( Figure 3B , C). GFL-MCAK bound exclusively to the ends of the majority of the MTs (67 ± 6%), while 25 ± 4% of the MTs had GFL-MCAK bound to both the lattice and MT ends. GFL- 
FL-MCAK depolymerizes MTs more efficiently than MD-MCAK
Because MD-MCAK did not bind with high affinity to MT ends, we expected it to be less efficient at inducing MT depolymerization because end binding is thought to be an essential part of the depolymerization mechanism (Desai et al., 1999; Hunter et al., 2003) . However, our cellular and sedimentation-based depolymerization assays revealed no significant reduction in the activity of MD-MCAK compared to FL-MCAK; therefore we needed an assay that was capable of reproducibly detecting subtle changes in depolymerization activity. Because we found that real-time MT depolymerization assays are highly variable and difficult to quantify accurately, we used a sedimentation assay in which we added increasing concentrations of enzyme to determine the effective concentration at which each enzyme gives 50% MT depolymerization (EC 50 ; Figure 4 ). For each MCAK concentration analyzed, the fraction of MT polymer to soluble tubulin heterodimer at a fixed time point was quantified and compared to the log of the enzyme concentration ( Figure 4B (Motulsky and Christopoulos, 2003) ). At high MCAK concentrations for both FL-MCAK and MD-MCAK, the MT polymer was almost completely converted to soluble tubulin heterodimer ( Figure 4A) ; however, there was a clear difference in the concentration of enzyme at which there was 50% MT polymer and 50% soluble tubulin heterodimer. The fit of the data to the dose-response curve provided an EC 50 for FL-MCAK of 5.6 nM and for MD-MCAK of 17 nM ( Figure 4C ). These data show that it takes nearly 3-fold more MD-MCAK than FL-MCAK to achieve the same molar quantity of soluble tubulin heterodimer relative to MT polymer.
FL-MCAK has higher ATPase activity than MD-MCAK
To determine the underlying kinetic differences between FL-MCAK and MD-MCAK that may contribute to the observed differences in depolymerization activity, we measured the ATPase activity of each protein at concentrations substoichiometric to MT polymer. In these assays, we used doubly stabilized MTs, which are more resistant to depolymerization, to minimize MT substrate loss during the assay and to prevent accumulation of tubulin heterodimers in the assay, which can also stimulate ATPase ), and exhibited MT-stimulated ATPase activity ( Figure 5A) ; however, the ATPase kinetics differed greatly between the two proteins ( Figure 5D ).
We observed that the k cat,MT for the FL-MCAK was significantly higher than that of the 
MD-MCAK has a higher affinity for soluble tubulin heterodimer
We were surprised that the K 0.5,Tubulin was much lower for MD-MCAK than for FL-MCAK, which suggested that MD-MCAK bound more tightly to tubulin heterodimer. However, our ATPase assays do not address the interaction of MCAK with MT polymer and tubulin heterodimer when both are present, a situation that is more physiologically relevant. To compare the relative binding of MCAK to MTs in the presence of tubulin heterodimer, we developed a MT cosedimentation competition assay in which FL-or MD-MCAK was incubated with a saturating concentration of doubly stabilized MTs in the presence of increasing concentrations of soluble tubulin heterodimer ( Figure 6A ). We quantified the amount of MCAK that partitioned to the supernatant (assumed to be associated with soluble tubulin heterodimer) or the pellet (associated with MTs). We found that as the tubulin heterodimer concentration was increased, MD-MCAK partitioned to the supernatant with the soluble tubulin heterodimer rather than in the pellet with the MT polymer ( Figure 6A ). At a 4:1 molar ratio of soluble tubulin heterodimer to MTs, only 30 ± 0.05% of the MD-MCAK remained in the pellet as compared to no tubulin heterodimer addition ( Figure   6B ). In contrast, as the concentration of tubulin heterodimer increased, the amount of FL-MCAK in the pellet remained relatively constant. These data are consistent with the hypothesis that MD-MCAK has a higher affinity for tubulin heterodimer than FL-MCAK. We propose that the high affinity of MD-MCAK for tubulin heterodimer acts to stabilize the MCAK-tubulin heterodimer complex, thereby, slowing its dissociation for rebinding to the MT end for another cycle of ATP-promoted MT depolymerization. 
MD-MCAK exhibits slower kinetics than FL-MCAK
Unlike most translocating kinesins, the ATPase activity of Kinesin-13 members is stimulated by MTs as well as by tubulin heterodimer (Moores et al., 2002; Hunter et al., 2003; Moores et al., 2003; Moore and Wordeman, 2004; Shipley et al., 2004) . This difference in MT-and tubulin heterodimerstimulated activity could be because Kinesin-13s recognize unique tubulin quaternary structures that are exposed only at the end of the MT or because they can bind directly to tubulin heterodimer (Desai et al., 1999) . Interestingly, it was recently shown that Xklp1 (Kinesin-4 Family) can translocate along MTs as well as regulate their dynamics (Bringmann et al., 2004) . The ATPase activity of Xklp1 is also stimulated by tubulin heterodimer, suggesting the intriguing possibility that tubulin heterodimer-stimulated ATPase activity is a conserved feature of kinesins that regulate MT dynamics. However, Kar3 (kinesin-14 family), which influences MT dynamics in yeast (Meluh and Rose, 1990; Saunders et al., 1997; Troxell et al., 2001 ) and depolymerizes MTs in vitro (Endow et al., 1994; Sproul et al., 2005) , exhibits only MTstimulated ATPase activity and shows much less robust depolymerization activity when compared to Kinesin-13 family members (Sproul et al., 2005) . Thus, even within the kinesin superfamily, the mechanism of MT depolymerization has diverged and highlights the need to study the detailed catalytic mechanism of multiple members within a kinesin subfamily.
Our findings that the tubulin heterodimer-stimulated ATPase activity is lower than MTstimulated ATPase activity for FL-MCAK are similar to what has been observed for mammalian MCAK (Hunter et al., 2003) , yet curiously the tubulin heterodimer-stimulated ATPase activity is equal to MTstimulated ATPase activity for the pKinI catalytic core (Moores et al., 2002; Moores et al., 2003; Shipley et al., 2004) . This may be due in part to the type of MT substrate used in the assay: a recent report showed that MCAK exhibited MT-stimulated ATPase activity comparable to that of tubulin heterodimer when long paclitaxel-stabilized MTs were used as a substrate (Moore and Wordeman, 2004) . Given that the ATPase activity of MCAK is highly stimulated by MT ends (Hunter et al., 2003; Moore and Wordeman, 2004) , it is possible that the end structures of GMPCPP-stabilized MTs may be slightly different than paclitaxel-stabilized MTs. Alternatively, the differences in ATPase activity may simply be a reflection of the length of MTs that were utilized in the assay (Hunter et al., 2003; Moore and Wordeman, 2004) or a reflection of the differences between the expressed proteins (the pKinI construct used contained only the catalytic core).
Although the Kinesin-13s are stimulated by both MTs and tubulin heterodimer, the relative activities and apparent substrate affinities of FL-MCAK and MD-MCAK are quite different. Our data suggest that although MD-MCAK still has a higher affinity for MTs than for tubulin heterodimer, it may be hampered in its depolymerization activity in part because its end binding ability is not as robust as FL-MCAK. For MD-MCAK the K 0.5,MT may also reflect both end and lattice affinities; therefore the decreased ATPase activity measured may reflect a reduction of activity due to non-productive lattice binding and compromised end binding.
Our data suggest that another difference between FL-MCAK and MD-MCAK is that a significant amount of MD-MCAK may remain tightly bound to tubulin heterodimer that is released during depolymerization. Consistent with this idea, MD-MCAK has a considerably higher affinity for soluble tubulin heterodimer than does FL-MCAK as assayed by binding competition assays. These results suggest that in the cellular transfection assay, MD-MCAK may be bound to free tubulin heterodimer and act as a tubulin sequestering protein in addition to a microtubule-depolymerizing enzyme. In the future it will be important to determine whether the ability of MCAK to sequester tubulin heterodimer is physiologically important.
Two Heads Are Better than One
Our data support a model in which dimerization of MCAK appears to be important for efficient Another model is that dimerization may contribute to processive depolymerization of stabilized MTs. One model of MCAK action is that the enzyme remains bound to the MT and continues to hydrolyze ATP while inducing tubulin heterodimer release from the MT end. This processivity seems to depend on the stability of the MT substrate (Hunter et al., 2003) , which in vivo could depend on the number of stabilizing proteins present. Perhaps dimerization of MCAK plays a vital role in the establishment of processivity. For example, conventional kinesin as a monomer can walk along the MT, but it is not processive (Berliner et al., 1995; Hancock and Howard, 1998; Romberg et al., 1998; Inoue et al., 2001) . If Kinesin-13s are processive depolymerizers, it is possible that monomeric Kinesin-13s are not processive depolymerizers in vitro, which could explain why MD-MCAK appears less efficient.
It is also possible that the differences between FL-MCAK and MD-MCAK are not a reflection solely of dimerization but are complicated by the presence of additional regulatory domains in the Cterminus. Deletion of the C-terminal nine amino acids of mammalian MCAK increases depolymerization activity in vivo and also increases ATPase activity in vitro (Moore and Wordeman, 2004) . The authors propose that MCAK binds weakly to the lattice, but that ATPase activity is inhibited by the far Cterminus until the enzyme reaches its high affinity binding site at the end of the MT (Moore and Wordeman, 2004) . From our transfection data, we found that truncation of 28 amino acids from the C-terminus of Xenopus MCAK, caused a small but significant decrease in depolymerization activity (Table   S1 ) contrary to previous findings (Moore and Wordeman, 2004) . Despite these differences, our monomeric MD-MCAK, which lacks the entire C-terminus, shows similar MT depolymerization in vivo, decreased affinity for MT ends, and decreased ATPase activity in vitro when compared to FL-MCAK. In addition, our preliminary data suggests that deletion of potential regulatory domains in either the N-or Ctermini do not significantly influence depolymerization activity when assayed under similar conditions.
However, it should be noted that the ionic strength utilized in the depolymerization assay buffers does affect the activity of several of the truncation mutants (our unpublished observations). Together these results suggest that Kinesin-13s have more than one mechanism for the control of ATPase activity, which is another example of the complexity of this enzyme family.
MD-MCAK binds less efficiently to MT ends
One interesting finding from our studies is that FL-MCAK has a much stronger preference for binding to MT ends relative to MD-MCAK. MD-MCAK may be unable to recognize the end structure of the MT as well as FL-MCAK, or it may be unable to reach the end by a non-directional mechanism such as 1D diffusion. It is also possible that other parts of the binding cycle, such as dissociation from the MT, may occur faster for MD-MCAK, and thus MD-MCAK may not remain on the MT end long enough to visualize its binding.
The nucleotide state of MCAK was also an important feature governing end binding. In contrast to previous findings (Desai et al., 1999; Moore and Wordeman, 2004) , we found that while FL-MCAK still showed specificity for the MT ends in the presence of MgAMPPNP, the amount of FL-MCAK at the ends only was significantly decreased. Our results are curious considering that the 1D diffusion of MCAK, proposed to be necessary for end-targeting, requires the presence of added nucleotide (Hunter et al., 2003) . However, we found that FL-MCAK bound most efficiently to MT ends without additional nucleotide, challenging this model. In comparison, studies involving the pKinI catalytic core have revealed that nucleotide state does not affect the affinity of pKinI binding to the MT lattice (Moores et al., 2003) . Overall, these studies indicate that nucleotide state plays a role in regulating end binding and not lattice binding affinity for Kinesin-13s.
A model for MCAK induced depolymerization
Given the difference in ATPase kinetics and end binding specificity, we propose the following model for how the two heads of MCAK may be utilized during MT depolymerization (Figure 7 ). by SDS-PAGE followed by Coomassie staining, and the amount of depolymerization was then quantified using NIH image. B. The combined data derived from at least 3 separate experiments were fit to the doseresponse curve (Eq. 2). C. A summary of the data derived from the graphs in part B. 
